BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2931019)

  • 41. [Cutaneous necrosis and rhabdomyolysis following the intravenous infusion of vasopressin].
    de Cuenca Morón B; Canga F; Moreno D; Rodríguez S; Solís Herruzo JA
    Rev Clin Esp; 1993 Feb; 192(2):79-82. PubMed ID: 8460239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.
    Nevens F; Broeckaert L; Rutgeerts P; Van Steenbergen W; Fevery J
    Hepatogastroenterology; 1995; 42(6):979-84. PubMed ID: 8847055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose vasopressin for acute variceal hemorrhage. Clinical advantages without adverse effects.
    Sirinek KR; Levine BA
    Arch Surg; 1988 Jul; 123(7):876-80. PubMed ID: 3260096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhabdomyolysis and cutaneous necrosis following intravenous vasopressin infusion.
    Moreno-Sánchez D; Casis B; Martín A; Ortiz P; Castellano G; Muñoz MT; Vanaclocha F; Solís-Herruzo JA
    Gastroenterology; 1991 Aug; 101(2):529-32. PubMed ID: 2065928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversible ischemic colitis after intravenous vasopressin therapy.
    Lambert M; de Peyer R; Muller AF
    JAMA; 1982 Feb; 247(5):666-7. PubMed ID: 6976443
    [No Abstract]   [Full Text] [Related]  

  • 46. Vasopressin-induced bullous disease and cutaneous necrosis.
    Korenberg RJ; Landau-Price D; Penneys NS
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 2):393-8. PubMed ID: 3525622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scrotal and abdominal skin necrosis complicating intravenous vasopressin therapy for bleeding esophageal varices.
    Gogel HK; Sherman RW; Becker LE
    Dig Dis Sci; 1985 May; 30(5):460-4. PubMed ID: 3157556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Torsade de pointes in a patient receiving intravenous vasopressin.
    Mauro VF; Bingle JF; Ginn SM; Jafri FM
    Crit Care Med; 1988 Feb; 16(2):200-1. PubMed ID: 3257726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Canine esophageal motor function: effects of arterial and intravenous vasopressin.
    Cho KJ; McGinnis BD
    AJR Am J Roentgenol; 1981 May; 136(5):961-4. PubMed ID: 6784535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous vasopressin in patients with portal hypertension: advantages of continuous infusion.
    Thomford NR; Sirinek KR
    J Surg Res; 1975 Feb; 18(2):113-7. PubMed ID: 1134080
    [No Abstract]   [Full Text] [Related]  

  • 51. Simultaneous infusion of nitroglycerin and nitroprusside to offset adverse effects of vasopressin during portosystemic shunting.
    Sirinek KR; Adcock DK; Levine BA
    Am J Surg; 1989 Jan; 157(1):33-7. PubMed ID: 2491934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vasopressin-related bullous disease of the legs.
    Colemont LJ; Harrier HD; Shoemaker WC
    J Clin Gastroenterol; 1991 Feb; 13(1):91-3. PubMed ID: 2007755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous intravenous vasopressin in active upper gastrointestinal bleeding.
    Fogel MR; Knauer CM; Andres LL; Mahal AS; Stein DE; Kemeny MJ; Rinki MM; Walker JE; Siegmund D; Gregory PB
    Ann Intern Med; 1982 May; 96(5):565-9. PubMed ID: 7041728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasopressin-induced amber-like skin necrosis.
    Lin RY; Du SL; Yeh HS; Wang WM
    Dermatology; 1997; 195(3):271-3. PubMed ID: 9407178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cimetidine, vasopressin and chronotropic incompetence.
    Nikolic G; Singh JB
    Med J Aust; 1982 Oct; 2(9):435-6. PubMed ID: 6983645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Muscular necrosis following administration of vasopressin].
    Moreno Sánchez D; Canga Rodríguez-Valcárcel F; De Cuenca Morón B
    Rev Esp Enferm Dig; 1991 Feb; 79(2):160-2. PubMed ID: 2059519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purpuric drug eruption possibly due to gefinitib (Iressa).
    Kurokawa I; Endo K; Hirabayashi M
    Int J Dermatol; 2005 Feb; 44(2):167-8. PubMed ID: 15689221
    [No Abstract]   [Full Text] [Related]  

  • 58. [TREATMENT OF HEMORRHAGING ESOPHAGEAL VARICES].
    HAEMMERLI UP
    Dtsch Med Wochenschr; 1965 Feb; 90():311-2. PubMed ID: 14239720
    [No Abstract]   [Full Text] [Related]  

  • 59. Myoglobinuria and acute renal failure associated with intravenous vasopressin infusion.
    Affarah HB; Mars RL; Someren A; Smith HW; Heymsfield SB
    South Med J; 1984 Jul; 77(7):918-21. PubMed ID: 6610943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pitressin-induced myocardial injury and depression in a young woman.
    Beller BM; Trevino A; Urban E
    Am J Med; 1971 Nov; 51(5):675-9. PubMed ID: 5315830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.